Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It
is designed to obtain information on the efficacy and safety of 3 different doses of
tofacitinib.